Lee Schoentrup2018-04-26T08:56:54+00:00April 26th, 2018|Press Releases|
FOR IMMEDIATE RELEASE: SEATTLE | April 26, 2018: A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI’s leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection [...]
Lee Schoentrup2018-04-25T09:02:47+00:00April 25th, 2018|Blog|
When asked about the deadliest creatures in the world, thoughts often turn to sharks, snakes or even lions. But the list is topped by a tiny, buzzing insect that packs a powerful punch: the mosquito, which transmits parasites that cause [...]
Lee Schoentrup2018-04-06T09:43:19+00:00April 6th, 2018|Press Releases|
FOR IMMEDIATE RELEASE: SEATTLE | April 6, 2018: As IDRI (Infectious Disease Research Institute) celebrates its 25th anniversary in 2018, the organization is developing a strategic plan to hone current strengths while embarking upon bold new initiatives including next generation [...]
Lee Schoentrup2018-04-03T16:10:18+00:00April 3rd, 2018|News|
Lee Schoentrup2018-04-03T15:28:13+00:00April 3rd, 2018|Events|
May 18, 2018 Bike Everywhere Day 2018 6-9 a.m., Friday, May 18, 2018 1616 Eastlake Avenue East, Seattle, WA IDRI (Infectious Disease Research Institute), Grand Central Bakery, Alexandria Real Estate, the local chapter of the MS Society & Caliber Home [...]
Lee Schoentrup2018-03-29T14:06:27+00:00March 29th, 2018|News|
Lee Schoentrup2018-03-29T14:01:28+00:00March 29th, 2018|News|
Lee Schoentrup2018-03-29T13:48:03+00:00March 29th, 2018|Press Releases|
FOR IMMEDIATE RELEASE: SEATTLE | March 29, 2018: The Global Health Innovative Technology Fund (GHIT) has awarded the University of Florida (UF) and partners, including IDRI (Infectious Disease Research Institute), $3.2 million to advance a promising vaccine to prevent transmission [...]
Lee Schoentrup2018-03-27T10:00:56+00:00March 24th, 2018|Press Releases|
FOR IMMEDIATE RELEASE: SEATTLE | March 24, 2018 : Researchers at IDRI (Infectious Disease Research Institute), the South African Tuberculosis Vaccine Initiative (SATVI) at the University of Cape Town (UCT) and Aeras have released the first results from a clinical trial [...]
Lee Schoentrup2018-03-27T09:55:45+00:00March 23rd, 2018|Press Releases|
FOR IMMEDIATE RELEASE: Seattle | March 23, 2018: IDRI’s tuberculosis drug discovery efforts continue to expand with a recently awarded grant extension of $3.8 million from the Bill & Melinda Gates Foundation. The additional funding was awarded to Tanya [...]
